WA research centre appeals to philanthropy
28 October, 2002 by Pete YoungA young cooperative research institute in Western Australia is hoping wealthy philanthropists will help it plug a funding gap.
Closer Sino-Australian biotech ties tipped
25 October, 2002 by Melissa TrudingerA conference in China attended by two Australian scientists may lead to closer links between the two countries.
NSW incubator appoints associate director
23 October, 2002 by Iain ScottThe NSW government's new BioFirst biotechnology incubator is on track for its February 2003 opening and has made named a high-level tech transfer specialist as its associate director.
Khan attacks Biota board performance, pay
23 October, 2002 by Pete YoungThe performance and pay of Biota Holdings' directors have been attacked by the drug discovery company's largest shareholder.
Automation specialist a winner
23 October, 2002 by Pete YoungLab automation specialist Advanced Rapid Robotic Manufacturing (ARRM) is simultaneously winning professional accolades and expanding its revenue base.
'Baby' biotechs targeted by NSW seminar
21 October, 2002 by Iain ScottA free seminar has been set down for November 13 in Sydney, with the aim of letting young biotechnology companies into the secrets of developing management strategies that will allow them to survive adverse events.
Biota rejects Bigshop board demand
21 October, 2002 by Pete YoungA bid by Perth lawyer and financier Farooq Khan to force his way onto the board of Biota Holdings has been rejected by the drug discovery company.
Cash burn out, earnings in at Amrad
17 October, 2002 by Melissa TrudingerAmrad chairman Olaf O'Duill doesn't like it when companies use "cash burn" to absolve themselves of their spending, and wants Amrad to think about cash earned, he told the company's annual general meeting yesterday.
Challenger readies for Asia VC play
17 October, 2002 by David BinningThe Kerry Packer-backed financial services and venture capital (VC) group Challenger International is nearing the end of negotiations to form a biotech VC fund out of Singapore which will trawl for investment opportunities across Asia, Australia and New Zealand, the company revealed on Wednesday.
Challenger betting on biotech for super boom
16 October, 2002 by David BinningPerched at the top of the ABN Amro Building in the heart of Sydney's 'big end' of town, Sean Mordaunt, business development manager with Challenger International's Corporate Superannuation Fund, thrives on the manic energy pulsing through the busy business hub and the harbour below.
Xcell move disappoints stranded WA researchers
15 October, 2002 by Melissa TrudingerResearchers at the Optical and Biomedical Engineering Laboratory (OBEL) at the University of WA were left surprised and disappointed after a decision by Perth-based company Xcell Diagnostics to withdraw funding from the lab's skin cancer project, which aimed to develop a new optical pen probe technique for early detection of skin cancers.
Bio-IT hot topic at upcoming seminars
15 October, 2002 by Iain ScottResearch firm IDC is to host two breakfast briefings on the bio-IT industry, with a particular focus on Australia and the Asia-Pacific.
South Africans quick to pick up Iatia technology
15 October, 2002 by Melissa TrudingerIatia's QPe phase imaging technology proved popular at the recent International Congress on Electron Microscopy in Durban, South Africa, according to CEO Brian Powell.
Pi2 heads for the great outdoors
15 October, 2002 by Iain ScottSydney-based company Pi2 Limited has touted a new business strategy with two acquisitions, one in life sciences and the other in outdoor advertising.
AstraZeneca plans for growth in Qld natural products centre
15 October, 2002 by Pete YoungPharmaceutical company AstraZeneca plans to augment the Queensland-based natural product research centre in which it has invested $55 million since 1993.
